Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
McKesson
Medtronic
Express Scripts
Boehringer Ingelheim

Last Updated: May 19, 2022

CLINICAL TRIALS PROFILE FOR MUCINEX DM


✉ Email this page to a colleague

« Back to Dashboard

505(b)(2) Clinical Trials for Mucinex Dm

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT00902707 ↗ Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung Completed Reckitt Benckiser Inc. Phase 1 2009-05-01 The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
OTC NCT00902707 ↗ Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung Completed Reckitt Benckiser LLC Phase 1 2009-05-01 The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
OTC NCT00902707 ↗ Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung Completed University of North Carolina, Chapel Hill Phase 1 2009-05-01 The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for Mucinex Dm

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00441246 ↗ Phase 4 Study - Mucinex D as Adjunct Therapy Completed Adams Respiratory Therapeutics Phase 4 2007-02-01 The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.
NCT00902707 ↗ Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung Completed Reckitt Benckiser Inc. Phase 1 2009-05-01 The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
NCT00902707 ↗ Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung Completed Reckitt Benckiser LLC Phase 1 2009-05-01 The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Mucinex Dm

Condition Name

Condition Name for Mucinex Dm
Intervention Trials
Healthy Subjects 7
Acute Respiratory Infection 2
Acute Upper Respiratory Track Infection 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Mucinex Dm
Intervention Trials
Respiratory Tract Infections 4
Infections 4
Infection 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Mucinex Dm

Trials by Country

Trials by Country for Mucinex Dm
Location Trials
United States 61
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Mucinex Dm
Location Trials
North Carolina 5
Ohio 3
Nebraska 3
Massachusetts 3
Kentucky 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Mucinex Dm

Clinical Trial Phase

Clinical Trial Phase for Mucinex Dm
Clinical Trial Phase Trials
Phase 4 3
Phase 2/Phase 3 1
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Mucinex Dm
Clinical Trial Phase Trials
Completed 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mucinex Dm

Sponsor Name

Sponsor Name for Mucinex Dm
Sponsor Trials
Reckitt Benckiser LLC 9
Reckitt Benckiser Inc. 6
Adams Respiratory Therapeutics 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Mucinex Dm
Sponsor Trials
Industry 17
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
McKinsey
Boehringer Ingelheim
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.